US FDA’s Breakthrough Program Needs Higher Standard For Comparators, NEJM Says
This article is behind a paywall. Readers will have to pay for full access to the article.
Harvard Medical School researchers call for inclusion of off-label drugs, accelerated approvals, and dietary supplements in the definition of 'existing therapies.'
Read the full article here!health law policy